Skip to main content
Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia
- Author(s): Giacomini, Kathleen
- Witte, John
- Andreadis, Charalambos
- Yee, SW
- Mefford, JA
- Singh, N
- Percival, ME
- Stecula, A
- Yang, K
- Witte, JS
- Takahashi, A
- Kubo, M
- Matsuda, K
- et al.
Published Web Location
http://europepmc.org/articles/PMC4068832?pdf=renderNo data is associated with this publication.
Abstract
Acute myeloid leukemia (AML) is a clinically heterogeneous disease, with a 5-year disease-free survival (DFS) ranging from under 10% to over 70% for distinct groups of patients. At our institution, cytarabine, etoposide and busulfan are used in first or se
Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.